BULL Pharmachem
Kalbadevi, Mumbai, Maharashtra
GST No. 27AKFPJ6383E1Z2
TrustSEAL Verified
Call 08048973119 88% Response Rate
SEND EMAIL
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 70 mg |
| Pack Size | 1*60 Tablet |
| Brand Name | Spnib 70 |
| Manufacturer | Zydus |
| Shelf Life | 24 Months |
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 4 mg |
| Brand | Lenva 4 |
| Pack Size | 6*1*10 |
| Pack Type | Strip |
| Form | Capsule |
Lenvatinib is a powerful multi-kinase inhibitor used to treat advanced cancers, including thyroid, liver, and kidney cancers. It works by blocking tumor angiogenesis and cell proliferation, effectively slowing disease progression and extending survival in patients with difficult-to-treat solid tumors.
Product Details:
| Minimum Order Quantity | 1 Box |
| Brand | Lentris 10 |
| Pack Size | 3*10 |
| Shelf Life | 24 Months |
| Form | Capsules |
| Strength | 10 mg |
Lenvatinib is a powerful multi-kinase inhibitor used to treat advanced cancers, including thyroid, liver, and kidney cancers. It works by blocking tumor angiogenesis and cell proliferation, effectively slowing disease progression and extending survival in patients with difficult-to-treat solid tumors.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 4 mg |
| Brand | Lentris 4 |
| Shelf Life | 24 Months |
| Manufacturer | Mylan |
| Pack Size | 3*10 |
Lenvatinib is a powerful multi-kinase inhibitor used to treat advanced cancers, including thyroid, liver, and kidney cancers. It works by blocking tumor angiogenesis and cell proliferation, effectively slowing disease progression and extending survival in patients with difficult-to-treat solid tumors.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 100 mg |
| Brand | Ribaxa |
| Packaging Type | Bottle |
| Packaging Size | 1*60 |
| Shelf Life | 24 Months |
| Manufacturer | Dr. Reddy's |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 100 mg |
| Packaging Type | Strip |
| Packaging Size | 6*10 |
| Brand | Cyendiv |
| Shelf Life | 24 Months |
Nintedanib is a potent, orally administered tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and certain non-small cell lung cancers. It slows disease progression by inhibiting pathways that drive fibrosis and abnormal tissue remodeling.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 150 mg |
| Packaging Type | Strip |
| Packaging Size | 6*10 |
| Brand | Cyendiv |
| Shelf Life | 24 Months |
Nintedanib is a potent, orally administered tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and certain non-small cell lung cancers. It slows disease progression by inhibiting pathways that drive fibrosis and abnormal tissue remodeling.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 150 mg |
| Brand | Ibyra150 |
| Packaging Type | Bottle |
| Packaging Size | 1*60 |
| Shelf Life | 24 Months |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 100 mg |
| Brand | Bdparp |
| Packaging Type | Bottle |
| Packaging Size | 1*56 |
| Shelf Life | 24 Month |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 100 mg |
| Brand | Ibyra100 |
| Packaging Type | Bottle |
| Packaging Size | 1*60 |
| Shelf Life | 24 Months |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 150 mg |
| Brand | Bdparp |
| Packaging Type | Bottle |
| Packaging Size | 1*28 |
| Shelf Life | 24 Months |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 150 mg |
| Brand | Lynza |
| Packaging Type | Bottle |
| Packaging Size | 1*30 |
| Shelf Life | 24 Months |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 100 mg |
| Brand | Lynza |
| Packaging Type | Bottle |
| Packaging Size | 1*30 |
| Shelf Life | 24 Months |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 150 mg |
| Brand | Ribaxa |
| Packaging Type | Bottle |
| Packaging Size | 1*60 |
| Shelf Life | 24 Months |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 100 mg |
| Brand | Bracanat100 |
| Packaging Type | Bottle |
| Packaging Size | 1*30 |
| Shelf Life | 36 Month |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 150 mg |
| Brand | Bracanat150 |
| Packaging Type | Bottle |
| Packaging Size | 1*30 |
| Shelf Life | 36 Months |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 150 mg |
| Brand | Lynparza |
| Packaging Type | Bottle |
| Packaging Size | 1*120 |
| Shelf Life | 24 Months |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 100 mg |
| Brand | Lynparza |
| Packaging Type | Bottle |
| Packaging Size | 1*120 |
| Shelf Life | 24 Months |
Olaparib is a potent oral PARP inhibitor used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. By blocking DNA repair in cancer cells, it induces synthetic lethality, selectively targeting tumor cells and significantly improving progression-free survival in advanced malignancies.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 200 mg |
| Manufactured By | Biocon |
| Form | Tablet |
| Shelf Life | 24 Months |
| Pack Size | 1*30 |
Pazopanib tablet is a targeted anti-cancer therapy used to treat advanced renal cell carcinoma and soft tissue sarcoma. As a tyrosine kinase inhibitor, it disrupts tumor growth and blood vessel formation, offering significant clinical benefit. It is taken orally under medical supervision.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 400 mg |
| Manufactured By | Biocon |
| Form | Tablet |
| Shelf Life | 24 Months |
| Pack Size | 1*30 |
Pazopanib tablet is a targeted anti-cancer therapy used to treat advanced renal cell carcinoma and soft tissue sarcoma. As a tyrosine kinase inhibitor, it disrupts tumor growth and blood vessel formation, offering significant clinical benefit. It is taken orally under medical supervision.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 400 mg |
| Manufactured By | Hetero Healthcare |
| Form | Tablet |
| Shelf Life | 24 Months |
| Pack Size | 1*30 |
Pazopanib tablet is a targeted anti-cancer therapy used to treat advanced renal cell carcinoma and soft tissue sarcoma. As a tyrosine kinase inhibitor, it disrupts tumor growth and blood vessel formation, offering significant clinical benefit. It is taken orally under medical supervision.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 400 mg |
| Manufactured By | Natco |
| Form | Tablet |
| Shelf Life | 24 Months |
| Pack Size | 1*30 |
Pazopanib tablet is a targeted anti-cancer therapy used to treat advanced renal cell carcinoma and soft tissue sarcoma. As a tyrosine kinase inhibitor, it disrupts tumor growth and blood vessel formation, offering significant clinical benefit. It is taken orally under medical supervision.
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 200 mg |
| Manufactured By | Natco |
| Form | Tablet |
| Shelf Life | 24 Months |
| Pack Size | 1*30 |
Pazopanib tablet is a targeted anti-cancer therapy used to treat advanced renal cell carcinoma and soft tissue sarcoma. As a tyrosine kinase inhibitor, it disrupts tumor growth and blood vessel formation, offering significant clinical benefit. It is taken orally under medical supervision.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 12.5 mg |
| Generic Name | Sunitinib Malate Capsules |
| Brand | Sutinat 12.5 |
| Shelf Life | 36 Months |
| Manufacturer | Natco |
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 25 mg |
| Generic Name | Sunitinib Malate Capsules |
| Shelf Life | 36 Months |
| Brand | Sutinat 25 |
| Manufacturer | Natco |
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 12.5 mg |
| Brand | Sutekast-12.5 |
| Shelf Life | 24 Months |
| Manufacturer | Aprazer |
| Pack Size | 4*7 |
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 50 mg |
| Generic Name | Sunitinib Malate Capsules |
| Brand | Sutinat 50 |
| Manufacturer | Natco |
| Shelf Life | 36 Months |
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 25 mg |
| Generic Name | Sunitinib Malate Capsules |
| Manufacturer | Aprazer |
| Brand | Sutekast-25 |
| Shelf Life | 24 Months |
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 50 mg |
| Generic Name | Sunitinib Malate Capsules |
| Manufacturer | Aprazer |
| Brand | Sutekast-50 |
| Shelf Life | 24 Months |
Product Details:
| Minimum Order Quantity | 1 Box |
| Dose/Strength | 250 mg |
| Manufacturer | Natco |
| Shelf Life | 24 Months |
| Generic Name | Gefetininb IP |
| Pack Size | 1*30 |
Gefitinib tablets are used to treat non-small cell lung cancer (NSCLC) with EGFR mutations. By inhibiting the epidermal growth factor receptor (EGFR), it blocks cancer cell growth and spread, improving survival and quality of life in affected patients.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 4 mg |
| Storage Condition | Room Temperature |
| Brand | Pomalid |
| Shelf Life | 24 Months |
| Manufacturer | Natco |
Pomalidomide is a potent immunomodulatory agent used primarily to treat multiple myeloma in patients unresponsive to prior therapies. It inhibits cancer cell growth, modulates the immune response, and reduces inflammation, often combined with dexamethasone for enhanced efficacy in relapsed or refractory cases.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 4 mg |
| Storage Condition | Room Temperature |
| Shelf Life | 24 Months |
| Brand | Pomide |
| Manufacturer | Hetero Healthcare |
Pomalidomide is a potent immunomodulatory agent used primarily to treat multiple myeloma in patients unresponsive to prior therapies. It inhibits cancer cell growth, modulates the immune response, and reduces inflammation, often combined with dexamethasone for enhanced efficacy in relapsed or refractory cases.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 2 mg |
| Storage Condition | Room Temperature |
| Shelf Life | 24 Months |
| Brand | Pomide |
| Manufacturer | Hetero Healthcare |
Pomalidomide is a potent immunomodulatory agent used primarily to treat multiple myeloma in patients unresponsive to prior therapies. It inhibits cancer cell growth, modulates the immune response, and reduces inflammation, often combined with dexamethasone for enhanced efficacy in relapsed or refractory cases.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 1 mg |
| Storage Condition | Room Temperature |
| Shelf Life | 24 Months |
| Brand | Pomide |
| Manufacturer | Hetero Heathcare |
Pomalidomide is a potent immunomodulatory agent used primarily to treat multiple myeloma in patients unresponsive to prior therapies. It inhibits cancer cell growth, modulates the immune response, and reduces inflammation, often combined with dexamethasone for enhanced efficacy in relapsed or refractory cases.
Product Details:
| Minimum Order Quantity | 1 Box |
| Storage Condition | Room Temperature |
| Shlef Life | 24 Month |
| Brand | Pomalong 4 |
| Manufacturer | Cipla |
| Strength | 2 mg |
Pomalidomide is a potent immunomodulatory agent used primarily to treat multiple myeloma in patients unresponsive to prior therapies. It inhibits cancer cell growth, modulates the immune response, and reduces inflammation, often combined with dexamethasone for enhanced efficacy in relapsed or refractory cases.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 1 mg |
| Storage Condition | Room Temperature |
| Shelf Life | 24 Months |
| Manufacturer | Cipla |
| Brand | Pomalong 1 |
Pomalidomide is a potent immunomodulatory agent used primarily to treat multiple myeloma in patients unresponsive to prior therapies. It inhibits cancer cell growth, modulates the immune response, and reduces inflammation, often combined with dexamethasone for enhanced efficacy in relapsed or refractory cases.
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 2 mg |
| Storage Condition | Room Temperature |
| Shelf Life | 24 Month |
| Brand | Pomalong 2 |
| Manufacturer | Cipla |
Pomalidomide is a potent immunomodulatory agent used primarily to treat multiple myeloma in patients unresponsive to prior therapies. It inhibits cancer cell growth, modulates the immune response, and reduces inflammation, often combined with dexamethasone for enhanced efficacy in relapsed or refractory cases.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Packaging Size | 30 Capsules |
| Strength | 100 mg |
| Packaging Type | Bottle |
| Shelf Life | 24 Months |
| Brand | Acaone100 |
Acalabrutinib capsules are Bruton’s tyrosine kinase (BTK) inhibitors used to treat certain B-cell malignancies like mantle cell lymphoma and chronic lymphocytic leukemia. They block BTK signaling, reducing cancer cell survival and spread, offering targeted therapy with fewer side effects than traditional chemotherapy.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Packaging Size | 30 Capsules |
| Strength | 100 mg |
| Packaging Type | Bottle |
| Brand | Acalnib |
| Shelf Life | 24 Months |
Acalabrutinib capsules are Bruton’s tyrosine kinase (BTK) inhibitors used to treat certain B-cell malignancies like mantle cell lymphoma and chronic lymphocytic leukemia. They block BTK signaling, reducing cancer cell survival and spread, offering targeted therapy with fewer side effects than traditional chemotherapy.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Packaging Size | 30 Capsules |
| Strength | 100 mg |
| Packaging Type | Bottle |
| Brand | Acabrunat |
| Shelf Life | 24 Months |
Acalabrutinib capsules are Bruton’s tyrosine kinase (BTK) inhibitors used to treat certain B-cell malignancies like mantle cell lymphoma and chronic lymphocytic leukemia. They block BTK signaling, reducing cancer cell survival and spread, offering targeted therapy with fewer side effects than traditional chemotherapy.